Mulmit

MeiraGTx Holdings plcMeiraGTx Holdings plc

MGTX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3181,391,000-105,968,000-114,201,000-1.42
2024-12-3133,279,000-164,212,000-147,791,000-2.12
2023-12-3114,017,000-137,061,000-84,027,000-1.49

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-18Forbes AlexandriaPRESIDENT & CEO62,000
2026-07-21Giroux RichardCFO & COO56,000
2026-07-07Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY2,547
2026-07-07Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY25,112
2026-06-25Wollin Robert JGENERAL COUNSEL AND SECRETARY100,000
2026-06-25Zeldin Robert KCHIEF MEDICAL OFFICER100,000
2026-06-25Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY70,000
2026-06-25Giroux RichardCFO & COO980,000
2026-06-25Forbes AlexandriaPRESIDENT & CEO980,000
2026-06-11Yu Debra60,000
2026-06-11Hukkelhoven Ellen60,000
2026-06-11Harris Keith R.106,441

8-K events

FiledItems
2026-08-13Results of operations · Financial statements and exhibits
2026-07-07Entry into a material agreement · Termination of a material agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
2026-06-15Submission of matters to a vote
2026-05-14Results of operations · Financial statements and exhibits
2026-04-24Entry into a material agreement · Financial statements and exhibits
2026-04-16Entry into a material agreement · Financial statements and exhibits
2026-04-16Entry into a material agreement · Termination of a material agreement · Completed acquisition or disposition of assets · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-04-16Regulation FD disclosure · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.